Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2006-06-27
2006-06-27
Epps-Ford, Janet L. (Department: 1633)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C435S006120, C435S325000, C435S375000, C424S093210
Reexamination Certificate
active
07067318
ABSTRACT:
A method for transfecting T cells with a nucleic acid molecule comprising a gene such that the gene is expressed in the T cells is described. The T cells are stimulated and proliferating prior to introduction of the nucleic acid molecule.
REFERENCES:
patent: 5272082 (1993-12-01), Santoli et al.
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5443983 (1995-08-01), Ochoa et al.
patent: 5733543 (1998-03-01), Nabel et al.
patent: 5738852 (1998-04-01), Robinson et al.
patent: 5827642 (1998-10-01), Riddell et al.
patent: 5858358 (1999-01-01), June et al.
patent: 6692964 (2004-02-01), June et al.
patent: WO-90/05541 (1990-05-01), None
patent: WO-94/12196 (1994-06-01), None
patent: WO-94/29436 (1994-12-01), None
patent: WO-95/03408 (1995-02-01), None
patent: WO-95/33823 (1995-12-01), None
patent: WO-95/34320 (1995-12-01), None
patent: WO-96/01122 (1996-01-01), None
patent: WO-96/02646 (1996-02-01), None
patent: WO-96/06942 (1996-03-01), None
Fundamental Immunology, Second Edition, ed. by WE Paul, Raven Press Ltd., New York, ch. 13 pp. 359-384.
Pullen, AM. Surperantigens in Encyclopedia of Immunology, IM Rotill, ed. Academic Press, New York, 1993, pp. 1406-1408.
Senventer Van et al., Costimulation of T cell receptor/CD3-mediated activation of resting human CD4+ cells by leukocyte funcioin-associated antigen-1 ligna inercellular cell adhesion molule-1 involves prolonged inolsito phosphol J. Immunol 149:3872-3880.
Culver et al., “In Vivo Expression and Survival of Gene-Modified T Lymphocytes in Rhesus Monkeys,” Human Gene Therapy, 1:399-410 (1990).
Cann et al., “Hight Efficiency Transfection of Primary Human Lymphocytes and Studies of Gene Expression,” Oncogene, 3:122-128 (1988).
Coghlan, “Gene Dream Fades Away” New Scientist, 148: 14-15 (1995).
Crystal, “Transfer of Genes to Humans: Early Lessons and Obstacles to Success” Science, 270:404-410 (1995).
Fauser, “Long-Term Expression of Gene Introduction into Normal Human T-Lymphocytes by Retroviral-Mediated Gene Transfer,” Journal of Cellular Biochemistry, 45:353-358 (1991).
Finer et al., “kat: A High-Efficiency Retroviral Transduction System for Primary Human T Lymphocytes,” Blood, 83(1):43-50 (1994).
Gunzburg et al., “Virus Vector Design in Gene Therapy” Molecular Medicine Today, 410-417 (1995).
Lowenthal et al., “Tumor Necrosis Factor αInduces Proteins that Bind Specifically to kB-like Enhancer Elements and Regulate Interleukin 2 Receptor α -chain Gene Expression in Primary Human T Lymphocytes,” PNAS USA, 86:2331-2335 (1989).
Mastrangelo et al. “Gene Therapy for Human Cancer: An Essay for Clinicians” Seminars in Oncology, 23(1):4-21 (1996).
Novak et al., “In Vitro Transfection of Fresh Thymocytes and T Cells Shows SUbset-Specific Expression of Viral Promoters,” Molecular and Cellular Biology, 12:1515-1527 (1992).
Orkin et al. “Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy” pp. 21-22, Dec. (1995).
Park et al., “Transcriptional Regulation of Interleukin 3 (IL3) in Primary Human T Lymphocytes,” Journal of Biological Chemistry, 268(9):6299-6308 (1993).
Philip et al., “Efficient and Sustained Gene Expression in Primary T Lymphocytes and Primary and Cultured Tumor Cells Mediated by Adeno-Associated Virus Plasmid DNA Complexed to Cationic Liposomes,” Molecular and Cellular Biology, 14:2411-2418 (1994).
Tiberghein et al., “Ganciclovir Treatment of Herpes Simplex Thymidine Kinase-Transduced Primary T Lymphocytes: An Approach for Specific In Vivo Donor T-Cell Depletion After Bone Marrow Transplantation?” Blood, 84(4):1333-1341 (1994).
Verma et al., “Gene therapy-promise, problems, and prospects” Nature, 389:239-242 (1997).
Weiss, “T Lymphocyte Activation”, ch. 13, Fundamental Immunology, Second Edition, ed. by WE Paul, Raven Press Ltd., New York, pp. 359-384 (1989).
U.S. Appl. No. 10/828,481, filed Apr. 20, 2004, June et al.
Sambucetti et al. “NF-kB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation,” The EMBO Journal, 1989, pp. 4251-4258, vol. 8, No. 13.
June Carl H.
Kim Suil
Thompson Craig B.
Epps-Ford Janet L.
Leavitt Maria
The Regents of the University of Michigan
The United States of America as represented by the Secretary of
Wilmer Cutler Pickering Hale and Dorr LLP
LandOfFree
Methods for transfecting T cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for transfecting T cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for transfecting T cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3674235